课题基金 / 基金详情

Traceable theranostics: tools for visualising drug delivery and therapeutic benefit in vivo

Traceable theranostics: tools for visualising drug delivery and therapeutic benefit in vivo
可追溯的治疗诊断学:体内药物输送和治疗效果可视化的工具
批准号:
FT110100284
负责人:
Prof Kristofer Thurecht
金额:
$47.75万
依托单位国家:
澳大利亚
项目类别:
ARC Future Fellowships
财政年份:
2012
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2012-01-01 至 2015-12-31

项目摘要

项目成果

Prof Kristofer Thurecht的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Forty-three thousand people died from cancer in Australia in 2010. The aim of this project is to advance the concept of 'personalised-therapy' through the development of novel imaging devices based on polymers that can 'switch-on' and deliver drugs in specific tissues, allowing more sensitive and earlier detection and monitoring of diseases and therapies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ARC Research Hub for Advanced Manufacture of Targeted Radiopharmaceuticals
  • 批准号:
    IH220100017
  • 项目类别:
    Industrial Transformation Research Hubs
  • 资助金额:
    $332.45万
  • 财政年份:
    2023
  • 负责人:
    Prof Kristofer Thurecht
  • 依托单位:
Understanding production and application of alpha emitting radionuclides
  • 批准号:
    LP220100450
  • 项目类别:
    Linkage Projects
  • 资助金额:
    $34.92万
  • 财政年份:
    2023
  • 负责人:
    Prof Kristofer Thurecht
  • 依托单位:
Smart affinity membranes for manufacture of high value therapeutic proteins
  • 批准号:
    LP180100486
  • 项目类别:
    Linkage Projects
  • 资助金额:
    $27.38万
  • 财政年份:
    2019
  • 负责人:
    Prof Kristofer Thurecht
  • 依托单位:
Facility for Characterisation of BioNanomaterials
  • 批准号:
    LE160100168
  • 项目类别:
    Linkage Infrastructure, Equipment and Facilities
  • 资助金额:
    $43.34万
  • 财政年份:
    2016
  • 负责人:
    Prof Kristofer Thurecht
  • 依托单位:
国内基金
海外基金
新型骨癌靶向诊断治疗(theranostics)铂化合物研究
  • 批准号:
    21401031
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    25.0万元
  • 批准年份:
    2014
  • 负责人:
    黄克斌
  • 依托单位: